Lubiprostone
Closed Solicitation Posted
- Solicitation number
- SPE2D2-25-R-0022
- Agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Logistics Agency (DLA) Troop Support Medical is soliciting a national requirements contract for Lubiprostone capsules, specifically Lubiprostone 24 MCG and 8 MCG formulations in 60-count bottles. This is a fully competitive, unrestricted commercial item procurement utilizing FAR Part 12 procedures open to all sources. The contract will serve as a national supply source for the Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons through DLA and VA prime vendor programs. The award will be made to the lowest-price technically acceptable offeror based on evaluation criteria including technical requirements, past performance, and pricing. Proposals must be submitted electronically through the DLA Internet Bid Board System (DIBBS) by November 17, 2025, at 3:00 PM EDT, with the original deadline of November 3, 2025, having been extended via amendment.
This procurement carries no set-aside designations and represents an unrestricted competitive acquisition with no identified incumbents. The estimated annual quantities are 66,932 bottles of 24 MCG capsules and 32,598 bottles of 8 MCG capsules, reflecting significant volume requirements across multiple federal healthcare agencies. The contract structure includes a one-year base period with four one-year option periods, providing potential for a five-year relationship with the successful contractor. Offerors must provide comprehensive documentation including FDA compliance information, manufacturing facility details, and business representations to demonstrate capability. Interested parties may direct questions to Jeremy Brown at (445) 737-5419 or jeremy.brown@dla.mil, and all proposals should be submitted through DIBBS at https://www.dibbs.bsm.dla.mil or Sam.Gov at https://sam.gov.
Notice text
The Defense Logistics Agency is listing a solicitation for a national requirements contract for Lubiprostone Capsules. Procurement details follow.
Lubiprostone 24MCG Capsules and Lubiprostone 8 MCG Capsules in 60 count bottles.
This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of Defense, Department of Veterans Affairs, Indian Health Service and Bureau of Prisons customers through the DLA and VA prime vendor programs. The annual usage estimates will be provided in the Schedule of Supplies section of the solicitation. This is a commercial item and will be solicited using FAR part 12. All sources may submit a proposal which shall be considered by the agency.
A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and Sam.Gov at https://sam.gov. Interested parties should contact Jeremy Brown at (445) 737-5419, (jeremy.brown@dla.mil) for any questions/comments. Interested parties are further advised to set up automated notifications of pre-solicitation or solicitation changes through this website. The current solicitation date is October of 2025.
Files
| File | Type | Posted |
|---|---|---|
| SF30_SPE2D225R00220001.pdf | ||
| Lubiprostone Solicitation - SPE2D2-25-R-0022.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| This notice | Solicitation | |
| Lubiprostone | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Methylphenidate ER | Medical Supply Chain | No set-aside | |
| 6505--Imatinib Tablets | National Acquisition Center | No set-aside | |
| Epinephrine Injector | Medical Supply Chain | No set-aside | |
| 6505--Sodium Bicarbonate Injection Vial Restricted to Made in America | National Acquisition Center | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity